1. Eldorado
  2. Zentrale und angegliederte Institute
  3. Leibniz-Institut für Arbeitsforschung an der TU Dortmund
  4. Excli - Experimental and Clinical Sciences
  5. 2020 - Volume 19
  6. Letters to the Editor 2020
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHeimfarth, Luana-
dc.contributor.authorSantos, Victor Santana-
dc.contributor.authorAraújo, Adriano Antunes de Souza-
dc.contributor.authorQuintans-Júnior, Lucindo José-
dc.contributor.authorMartins-Filho, Paulo Ricardo-
dc.date.accessioned2020-12-18T11:23:11Z-
dc.date.available2020-12-18T11:23:11Z-
dc.date.issued2020-11-09-
dc.identifier.citationHeimfarth, L., Santos, V. S. ., Araújo, A. A. de S. ., Quintans-Júnior, L. J. ., & Martins-Filho, P. R. . (2020). Ivermectin: Panacea or true promise for COVID-19. EXCLI Journal, 19, 1517-1519. https://doi.org/10.17179/excli2020-3022en
dc.identifier.issn1611-2156-
dc.identifier.urihttp://hdl.handle.net/2003/39937-
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-21827-
dc.language.isoen-
dc.publisherIfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmunden
dc.relation.ispartofseriesEXCLI Journal;Vol. 19 2020-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectSARS-CoV-2en
dc.subjectIvermectinen
dc.subjectDrugen
dc.subject.ddc610-
dc.titleIvermectinen
dc.title.alternativePanacea or true promise for COVID-19en
dc.typeText-
dc.type.publicationtypearticle-
eldorado.identifier.urlhttps://www.excli.de/index.php/excli/article/view/3022-
dcterms.accessRightsopen access-
eldorado.dnb.zdberstkatid2132560-1-
eldorado.secondarypublicationtrue-
Appears in Collections:Letters to the Editor 2020

Files in This Item:
File Description SizeFormat 
excli2020-3022.pdfDNB571.99 kBAdobe PDFView/Open


This item is protected by original copyright

View License
Show simple item record


This item is licensed under a Creative Commons License Creative Commons